July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Establishment of an in vitro photoreceptor model suitable for AMD research
Author Affiliations & Notes
  • Natalie Wagner
    Experimental Eye Research Institute, University Eye Hospital, Bochum, Germany
  • Maurice Gammel
    Experimental Eye Research Institute, University Eye Hospital, Bochum, Germany
  • Sabrina Reinehr
    Experimental Eye Research Institute, University Eye Hospital, Bochum, Germany
  • Jose Hurst
    Centre for Ophthalmology, University Eye Hospital, Tuebingen, Germany
  • Sven Schnichels
    Centre for Ophthalmology, University Eye Hospital, Tuebingen, Germany
  • Burkhard Dick
    Experimental Eye Research Institute, University Eye Hospital, Bochum, Germany
  • Stephanie C Joachim
    Experimental Eye Research Institute, University Eye Hospital, Bochum, Germany
  • Footnotes
    Commercial Relationships   Natalie Wagner, None; Maurice Gammel, None; Sabrina Reinehr, None; Jose Hurst, None; Sven Schnichels, None; Burkhard Dick, None; Stephanie Joachim, None
  • Footnotes
    Support  PRO RETINA-Foundation for Prevention of Blindness
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1339. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Natalie Wagner, Maurice Gammel, Sabrina Reinehr, Jose Hurst, Sven Schnichels, Burkhard Dick, Stephanie C Joachim; Establishment of an in vitro photoreceptor model suitable for AMD research. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1339.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The age-related macular degeneration (AMD) is a multifactorial disease; therefore, suitable models exist only to a limited extent. An established porcine degeneration model has been modified to enable improved photoreceptor cultivation and to make it applicable for AMD research.

Methods : Two methods, namely “filter” and “tweezers”, were tested to gain porcine neuroretina explants, with the ganglion cell layer facing down. Retinas were cultivated for 4 days and compared to explants gained via an established method, photoreceptors facing down. To characterize the explants optical coherence tomography (OCT; n=6/group), H&E staining, immunohistochemistry, and qRT-PCR (n=4/group) were performed. More specifically, morphology of cones (opsin), rods (rhodopsin), amacrine (calretinin), bipolar (Pkcα) and retinal ganglion cells (RBPMS, β-III-tubulin) was evaluated.

Results : OCT analyses revealed a decrease of retinal thickness to a lower extent in “tweezers” compared to “filter” (p≤0.001) and “established” method (p=0.04). Moreover, measurements of retinal thickness via H&E staining showed for both new methods (filter: 28.6±1.1 µm; tweezers: 28.2±0.8 µm) a significantly improved photoreceptor structure compared to the established method (22.6±1.1 µm; filter: p=0.002; tweezers: p=0.003). Additionally, the rhodopsin+ area was significantly increased in the “filter” (6.9±0.2 area[%]/image; p=0.0005) and “tweezers” group (6.3±0.1 area[%]/image; p=0.048) in contrast to the established one (5.4±0.1 area[%]/image). In contrast, the number of cones was only higher in “tweezers” method (162.0±1.3 cells/mm) compared to the established one (141.1±2.5 cells/mm; p=0.035). The amount of amacrine, bipolar and retinal ganglion cells was unaltered. On mRNA level, we revealed an upregulation of rhodopsin (filter: p=0.048) and opsin (tweezers: p=0.045) in both new methods compared to the established one.

Conclusions : This project aimed to develop a more suitable in vitro photoreceptor degeneration model. The cultivation by the “tweezer” method led to a significantly improved morphology, which made it more comparable to the in vivo situation. Subsequently, to establish the AMD model a co-cultivation of neuroretina and RPE-cells will follow. Consequently, this system may serve as a new model for AMD drug screening.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×